Author

Kata Szántó 1

1 University of Szeged,Szeged,Hungary

CHANGE IN THE EXPRESSION OF SERPIN E1, A POTENTIAL NEW DISEASE ACTIVITY MARKER, REFLECTS THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASE

Boldizsár Jójárt, Viktória Szabó, Arpad Varga, Kata Szántó, Diána Kata, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas

CHARACTERISTICS OF ANTI-TNF ALPHA THERAPY FOR ULCERATIVE COLITIS BETWEEN 2010-2016 IN HUNGARY

Anita Balint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Péter Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Tamás Molnár

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Lorant Gonczi, Kata Szántó, Klaudia Farkas, Tamás Molnár, Tamás Szamosi, Eszter Schäfer, Petra Anna Golovics, Barbara Dorottya Lovasz, Mark Juhasz, Árpád V. Patai, Aron Vincze, Patrícia Sarlós, Karoly Palatka, Alexandra Farkas, Gábor Tamás Tóth, Peter L Lakatos, Pal Miheller, Ákos Iliás

COMPARISON OF THE EFFECTIVENESS AND SAFETY OF THE VEDOLIZUMAB THERAPY USING IN COMBINATION WITH OR WITHOUT CYCLOSPORINE IN ULCERATIVE COLITIS

Tamás Resál, Kata Szántó, Daniella Pigniczki, Mariann Rutka, Renáta Bor, Anna Fabian, Zoltan Gabor Szepes, Klaudia Farkas, Ferenc Nagy, Tamás Molnár

DOES ANY CONNECTION EXIST BETWEEN BLOOD THIOPURINE LEVEL AND ANTI TNF DRUG LEVEL OR BODY COMPOSITION PARAMETERS - A CROSS-SECTIONAL STUDY IN A HUNGARIAN IBD CENTRE

Kata Szántó, Anna Fabian, András Lajos Szíjártó, Imre Földesi, Diána Kata, Zoltán András Mezei, Anita Balint, Renáta Bor, Klaudia Farkas, Ágnes Milassin, Mariann Rutka, Zoltan Gabor Szepes, Ferenc Nagy, Tamás Bubán, Szilvia Lovas, Karoly Palatka, Tamás Molnár

DOES ANY CONNECTION EXIST BETWEEN BLOOD THIOPURINE LEVEL AND ANTI TNF DRUG LEVEL OR BODY COMPOSITION PARAMETERS – A CROSS-SECTIONAL STUDY IN A HUNGARIAN IBD CENTRE

Kata Szántó

ENDOSCOPIC ULTRASOUND GUIDED FINE-NEEDLE ASPIRATION OF RECTAL AND PERIRECTAL LESIONS

Anna Fabian, Renáta Bor, Béla Vasas, Sándor Hamar, László Tiszlavicz, Anita Balint, László Czakó, Klaudia Farkas, Ágnes Milassin, Mariann Rutka, Kata Szántó, Tamás Molnár, Zoltán Szepes

EPIDEMIOLOGY, INCIDENCE OF COLORECTAL CANCER, MORTALITY AND THE USE OF BIOLOGICAL THERAPY IN ULCERATIVE COLITIS PATIENTS BETWEEN 2007-2016 IN HUNGARY

Tamás Molnár, Ágnes Milassin, Kata Szántó, Pater Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Klaudia Farkas

Fecal concentration of vedolizumab correlates with tissue drug levels and endoscopic activity in inflammatory bowel disease patients

Klaudia Farkas, Kata Szántó, Diána Kata, Imre Földesi, Tibor Nyári, Fanni Balogh, Mariann Rutka, Anita Balint, Renáta Bor, Anna Fabian, Ágnes Milassin, Zoltan Gabor Szepes, Ferenc Nagy, József Maléth, Tamás Molnár

Fecal microbiota composition of ulcerative colitis patents after restorative proctocolectomy with ileal pouch-anal anastomisis- comparative, prospective study from Hungary

Anita Balint, Klaudia Farkas, Bálint Kintses, Orsolya Méhi, Tamara Madacsy, József Maléth, Kata Szántó, Mariann Rutka, Péter Bacsur, Zoltan Gabor Szepes, Ferenc Nagy, Anna Fabian, Renáta Bor, Tamás Molnár

Item 1 - 10 / 21
1
2 3